4 completed, 2 recruiting, 1 unknown. 7 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Recruiting 2, Unknown 1 |
| Phase 3 | 3 | Recruiting 2, Completed 1 |
Follow Thyroiditis, Autoimmune: new trials by email Literature Review of Thyroiditis, Autoimmune trials Research Report on Thyroiditis, Autoimmune
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Colchicine for Autoimmune and Subacute Thyroiditis colchicine, Prednisolone, NSAID - Hashimoto Thyroiditis, Subacute Thyroiditis | Phase 2 / Phase 3 | Recruiting | Mansoura University | 300 | 2026-06-15 | 2026-07-29 |
| Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) linsitinib - Thyroid Eye Disease, Graves Orbitopathy | Phase 2 / Phase 3 | Recruiting | Sling Therapeutics, Inc. | 75 | 2023-10-11 | 2025-02-25 |
| A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) Linsitinib, Placebo - Thyroid Eye Disease, Graves Orbitopathy | Phase 2 / Phase 3 | Completed | Sling Therapeutics, Inc. | 90 | 2022-07-01 | 2026-09-23 |
| The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis Immunomodulatory, Thyroxine - Infertility, Autoimmune Thyroiditis | Phase 2 | Completed | Aljazeera Hospital | 194 | 2018-03-07 | 2024-12-27 |
| Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT Selenomethionine, Placebo - Thyroiditis Autoimmune | Phase 2 | Unknown | University of Siena | 60 | 2012-12-01 | 2014-11-27 |
| Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention) Anatabloc Supplement, Placebo - Thyroiditis, Autoimmune | Phase 2 | Completed | Rock Creek Pharmaceuticals, Inc. | 165 | 2012-03-01 | 2015-11-02 |
| Low-Level Laser Therapy in Chronic Autoimmune Thyroiditis Low-level Laser therapy - Autoimmune Thyroiditis | Phase 2 | Completed | University of Sao Paulo General Hospital | 43 | 2006-03-01 | 2010-05-24 |
Hashimoto Disease (5) · Thyroid Diseases (3) · Endocrine System Diseases (2) · Exophthalmos (2) · Eye Diseases (2) · Graves Ophthalmopathy (2) · Orbital Diseases (2) · Thyroiditis (2) · Infertility (1) · Inflammation (1) · Thyroiditis, Subacute (1)
Autoimmune Diseases (7) · Immune System Diseases (7) · Endocrine System Diseases (5) · Thyroiditis (5) · Thyroid Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Goiter (2) · Graves Disease (2) · Hyperthyroidism (2) · Genital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (2) · Anti-Inflammatory Agents, Non-Steroidal (1) · Colchicine (1) · Low-Level Light Therapy (1) · Prednisolone (1) · Selenomethionine (1) · Thyroxine (1)
Sling Therapeutics, Inc. (2) · Aljazeera Hospital (1) · Mansoura University (1) · Rock Creek Pharmaceuticals, Inc. (1) · University of Sao Paulo General Hospital (1) · University of Siena (1)
United States (3) · Egypt (2) · Brazil (1) · Canada (1) · Italy (1) · Saudi Arabia (1) · Spain (1) · United Kingdom (1)
Ahmed M Sayed, Prof. (1) · Amr A. El Sehrawy, MD, PhD, FRCPE (1) · Furio Pacini, MD (1) · Maria Varga, MD (1)